Presentation is loading. Please wait.

Presentation is loading. Please wait.

Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial 

Similar presentations


Presentation on theme: "Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial "— Presentation transcript:

1 Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial  Prof Steve Goodacre, PhD, Judith Cohen, PhD, Mike Bradburn, MSc, Prof Alasdair Gray, MD, Prof Jonathan Benger, MD, Prof Timothy Coats, MD  The Lancet Respiratory Medicine  Volume 1, Issue 4, Pages (June 2013) DOI: /S (13) Copyright © 2013 Elsevier Ltd Terms and Conditions

2 Figure 1 Study profile *Patients could meet ≥1 exclusion criteria.
The Lancet Respiratory Medicine 2013 1, DOI: ( /S (13) ) Copyright © 2013 Elsevier Ltd Terms and Conditions

3 Figure 2 Length of stay after initial hospital attendance
The Lancet Respiratory Medicine 2013 1, DOI: ( /S (13) ) Copyright © 2013 Elsevier Ltd Terms and Conditions


Download ppt "Intravenous or nebulised magnesium sulphate versus standard therapy for severe acute asthma (3Mg trial): a double-blind, randomised controlled trial "

Similar presentations


Ads by Google